Patents Assigned to Nordic Bioscience Diagnostics A/S
  • Patent number: 7632684
    Abstract: In an in vitro diagnostic test for osteoarthritis or rheumatoid arthritis, the amount or presence in a sample of anisomerised or optically inverted protein fragment is measured which derives from perlecan, bigylcan, decorin, fibrillin-1 or protocadherin or which is a specific sequence from aggrecan, type II collagen, COMP or CILP.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: December 15, 2009
    Assignee: Nordic Bioscience Diagnostics A/S
    Inventors: Stephan Christgau, Dennis B. Henriksen, Paul A. C. Cloos